Drug recall · July 25, 2018
MORphine 150 mg recall
Why: Lack of Assurance of Sterility: Potential leakage of bags.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
MORphine 150 mg (Morphine Sulfate, USP 150mg in 0.9% Sodium Chloride, USP QS 30mL). Volume 30 mL. Single dose syringe. Avella of Houston, 9265 Kirby Dr., Houston, TX 77054. NDC 42852-243-63
- Lots / codes
Lot #:2/26/18 2233 24363M, BUD 6/26/2018.
- Quantity
- 740 syringes
- Company
- Avella of Deer Valley, Inc. Store 38, Phoenix, AZ
- Distribution
- Nationwide in the USA
- Initiated
- June 12, 2018 · Voluntary: Firm initiated
- Classified
- July 19, 2018
- Reported
- July 25, 2018
- Ended
- January 24, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Morphine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.